%0 Journal Article %A Ponde, Noam %A Bradbury, Ian %A Lambertini, Matteo %A Ewer, Michael %A Campbell, Christine %A Ameels, Helene %A Zardavas, Dimitrios %A Di Cosimo, Serena %A Baselga, José %A Huober, Jens %A Izquierdo, Miguel %A Fumagalli, Debora %A Bozovic-Spasojevic, Ivana %A Maetens, Marion %A Harbeck, Nadia %A Pusztai, Lajos %A Berghorn, Michael %A Im, Young-Hyuck %A Borrego, Manuel Ruiz %A Chen, Dar-Ren %A Rodeheffer, Richard %A Piccart, Martine %A Suter, Thomas %A de Azambuja, Evandro %T Cardiac biomarkers for early detection and prediction of trastuzumab and/or lapatinib-induced cardiotoxicity in patients with HER2-positive early-stage breast cancer: a NeoALTTO sub-study (BIG 1-06). %D 2017 %U http://hdl.handle.net/10668/11951 %X Biomarkers of cardiac damages, such as troponin T (TnT) and the amino-terminal fragment of brain natriuretic peptide (NT-proBNP), may be useful as early predictors of cardiac dysfunction. The role of these biomarkers in patients receiving lapatinib and/or trastuzumab before anthracyclines is unknown. This study explores TnT and NT-proBNP as predictors of early cardiac toxicity in neoadjuvant breast cancer patients. This sub-study of the NEOALTTO trial tested if changes in the levels of TnT and NT-proBNP occurred after 2 weeks of anti-HER2 therapy (lapatinib, trastuzumab or their combination) alone and/or after 18 weeks of anti-HER2 therapy plus weekly paclitaxel. 173 and 172 were tested at all three timepoints for NT-proBNP and TnT, respectively. The incidence of biomarker elevation was overall low at all timepoints for all the three treatment arms. A total of 13 CEs in 11 patients occurred. Biomarker elevations in patients with CEs were very rare; only one patient with subsequent CE had a NT-proBNP elevation at baseline and at week 2. These results suggest that TnT and proBNP may not be useful as early predictors of cardiac toxicity in anthracycline-naïve patients receiving trastuzumab and/or lapatinib. %K Brain natriuretic peptide %K Cardiotoxicity %K HER2 positive breast cancer %K Lapatinib %K Troponin T %~